Literature DB >> 9518551

Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes.

M Shimizu1, A Nishida, H Zensho, M Miyata, S Yamawaki.   

Abstract

Our previous study has demonstrated that astrocytes derived from the rat frontal cortex contain 5-hydroxytryptamine (5-HT)7 receptors positively coupled to adenylyl cyclase. In this study, we observed a desensitization of 5-HT7 receptors induced by a treatment with agonists (0.1, 1, and 10 muM, 0.5 to 3.5 h). Maximum responses, but not the EC50 values, in the concentration-response curve of 5-HT-induced cyclic AMP formation were decreased after pretreatment with 5-HT. Pretreatment with 5-carboxamidotryptamine (5-CT) elicited a potent desensitization of 5-HT-induced cyclic AMP formation. Neither 2-methyl-5-HT nor alpha-methyl-5-HT caused the desensitization. When the astrocytes were treated with isoproterenol, N-ethylcarboxamidoadenosine, and dibutyryl cyclic AMP (all of which increase intracellular cyclic AMP levels), 5-HT-induced cyclic AMP responses were not affected. Conversely, adenylyl cyclase activity mediated by either isoproterenol or N-ethylcarboxamidoadenosine was attenuated by pretreatment with each of these agonists, but not 5-HT. In addition, our study showed that the administration of 5-HT, 5-CT, and 8-hydroxy-2-(di-n-propylamino)tetralin to the astrocytes stimulated cyclic AMP formation both in the presence and absence of forskolin, whereas in neuron-rich cultures of the frontal cortex, these agonists did not change basal cyclic AMP levels and decreased forskolin-stimulated cyclic AMP formation. Neurons may predominantly contain 5-HT1A receptors that are negatively coupled to adenylyl cyclase. These results suggest that 5-HT7 receptors are highly expressed in astrocytes but not in neuronal cells, and that pretreatment with their agonists results in a homologous desensitization of the receptors. Copyright 1997 Elsevier Science B. V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518551     DOI: 10.1016/s0006-8993(97)01185-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties.

Authors:  Isabelle Rauly-Lestienne; Elisa Boutet-Robinet; Marie-Christine Ailhaud; Adrian Newman-Tancredi; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-05       Impact factor: 3.000

2.  Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.

Authors:  A Otano; A García-Osta; S Ballaz; D Frechilla; J Del Río
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.

Authors:  Lir-Wan Fan; Abhay Bhatt; Lu-Tai Tien; Baoying Zheng; Kimberly L Simpson; Rick C S Lin; Zhengwei Cai; Praveen Kumar; Yi Pang
Journal:  J Neurochem       Date:  2015-01-28       Impact factor: 5.372

4.  Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine₇ receptors: evidence for in situ G protein-coupled receptor homodimer protomer cross-talk.

Authors:  Carol Smith; Nicole Toohey; Jessica A Knight; Michael T Klein; Milt Teitler
Journal:  Mol Pharmacol       Date:  2010-11-09       Impact factor: 4.436

Review 5.  Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases.

Authors:  Alejandro Quintero-Villegas; Sergio Iván Valdés-Ferrer
Journal:  Mol Med       Date:  2022-06-20       Impact factor: 6.376

6.  Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways.

Authors:  Vaibhav P Pai; Nelson D Horseman
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

7.  The 5-HT7 receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT7 receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus.

Authors:  Joanna Sowa; Magdalena Kusek; Marcin Siwiec; Joanna Ewa Sowa; Bartosz Bobula; Krzysztof Tokarski; Grzegorz Hess
Journal:  Psychopharmacology (Berl)       Date:  2018-09-28       Impact factor: 4.530

Review 8.  5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.

Authors:  Lucia Ciranna; Maria Vincenza Catania
Journal:  Front Cell Neurosci       Date:  2014-08-27       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.